• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cel-Sci Corporation Common Stock (NY:CVM)

    1.241 +0.101 (+8.84%)
    Streaming Delayed Price Updated: 11:15 AM EDT, Jul 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cel-Sci Corporation Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    News headline image
    US Stocks Mixed; Bank of America Tops Q2 Views ↗
    U.S. stocks traded mixed this morning, with the Dow Jones gaining around 70 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 34,655.10 while the NASDAQ fell 0.38% to... 
    Via Benzinga
    News headline image
    TDOC Stock Alert: Teladoc Doubles Down on Microsoft AI Partnership ↗
    Teladoc (TDOC) stock is on the move Tuesday as the company expands its Microsoft (MSFT) AI partnership to enhance Teladoc Health Solo. 
    Via InvestorPlace
    News headline image
    CMG Stock Alert: Chipotle Announces International Expansion Plan ↗
    Chipotle Mexican Grill (CMG) stock is in the news Tuesday after the restaurant chain announced plans for an international expansion. 
    Via InvestorPlace
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Is CEL-SCI (CVM) Stock Down 23% Today? ↗
    CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering. 
    Via InvestorPlace
    News headline image
    Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket ↗
    Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's... 
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
    It's time to start off trading for Tuesday with a breakdown of the biggest pre-market stock movers worth watching this morning. 
    Via InvestorPlace
    News headline image
    CEL-SCI Announces Pricing of Public Offering
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    CEL-SCI Announces Proposed Public Offering of Common Stock
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    CEL-SCI Concludes Positive Meeting With U.S. FDA Concerning Multikine’s Approval for Head & Neck Cancer
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    CEL-SCI Reports Phase 3 Tumor PD-L1 Biomarker Data Demonstrate Multikine’s Increased Efficacy and Points to Potential for Combination With Checkpoint Inhibitors for Head & Neck Cancer
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    CEL-SCI to Present Novel Data at AHNS 11th International Conference on Head and Neck Cancer—New Patent to Be Filed
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    Why CEL-SCI Shares Are Shooting Higher Today ↗
    CEL-SCI Corporation (NYSE: CVM) announced that the latest results from its pivotal Phase 3 study of Multikine, a presurgical cancer immunotherapy, were presented at the European Society for... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Histopathology and Tumor Biomarker Analysis Confirm CEL-SCI’s Multikine Significantly Prolonged Overall Survival in Head & Neck Cancer—Phase 3 Data Presented at ESTRO 2023
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    CEL-SCI Corporation Reports Second Quarter Fiscal 2023 Financial Results
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    Why BlackBerry Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket ↗
    Gainers Leju Holdings Limited (NYSE: LEJU) gained 103.7% to $7.25 in pre-market trading after jumping around 97% on Monday . 
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
    We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday! 
    Via InvestorPlace
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    CEL-SCI Announces $1.35 Million Underwritten Confidentially Marketed Public Offering of Common Stock
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    CEL-SCI to Pursue Canada’s Conditional Approval Pathway for Multikine in the Treatment of Head & Neck Cancer
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    CEL-SCI's Lead Head & Neck Cancer Candidate Shows 43% Survival Extension ↗
     
    Via Benzinga
    News headline image
    CEL-SCI’s Multikine Phase 3 Cancer Study Shows 43% Survival Extension
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
    We're getting into the biggest pre-market stock movers traders will want to keep an eye on Wednesday with the latest news! 
    Via InvestorPlace
    News headline image
    CEL-SCI to Present New Phase 3 Data at European Congress on Head & Neck Oncology
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
    Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. 
    Via Benzinga
    News headline image
    CEL-SCI Corporation Reports First Quarter Fiscal 2023 Financial Results
    From CEL-SCI Corporation
    Via Business Wire
    News headline image
    Tesla To $250? Here Are 10 Other Price Target Changes For Thursday ↗
    Morgan Stanley cut Tesla, Inc. (NASDAQ: TSLA) price target from $330 to $250. Morgan Stanley analyst Adam Jonas maintained an Overweight rating on the stock. Tesla shares rose 4.4% to $117.65 in... 
    Via Benzinga
    News headline image
    CEL-SCI Reports Fiscal 2022 Financial Results and Clinical & Corporate Developments
    From CEL-SCI Corporation
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.